• MSH2 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • Lyme Disease (Borrelia burgdorferi) Antibody, IgG, IgM, Immunoblot, Spinal Fluid
  • Alpha-galactosidase A (GLA) Mutation Analysis
  • Gene Expression Test for Monitoring Heart Transplant Rejection (AlloMap, MMDx Heart, myTAIHEART)
  • Bilirubin Total, Amniotic Fluid
  • Dextromethorphan, Urine
  • Acute Hepatitis Panel
  • Clobazam, Urine
  • Cannabinoid, Urine
  • Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
Medical Test

Overview
Access to Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization is restricted.